id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-291585-a6y8k1a5	Kow, Chia Siang	The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19	2020-08-28		.txt	text/plain	270	24	46	key: cord-291585-a6y8k1a5 title: The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19 cord_uid: a6y8k1a5 1 to describe the clinical characteristics and outcomes of patients with novel coronavirus disease 2019 (COVID-19) who developed acute arterial thrombosis. Based on the reported findings, we observed that the proportion of COVID-19 patients with major cardiovascular risk factors who developed acute arterial thrombosis is higher than that of their non-COVID-19 counterparts. This finding hinted at the possibility that thromboinflammation plays a greater role for the development of arterial thrombosis in COVID-19 patients than traditional cardiovascular risk factors. Therefore, we would like to propose routine antiplatelet therapy (low-dose aspirin, clopidogrel, ticagrelor, prasugrel, ticlopidine, and dipyridamole) for arterial thromboprophylaxis in COVID-19 patients who are deemed at heightened risk for the development of acute arterial thrombosis. Arterial thrombotic complications in hospitalized patients with COVID-19 The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome	./cache/cord-291585-a6y8k1a5.txt	./txt/cord-291585-a6y8k1a5.txt